Cargando…
A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee
An ethnopharmacological metanalysis was conducted with a large database available on antidiabetic activities of plant foods and medicines from the northern boreal forest, which are traditionally used by the indigenous Cree of James Bay, Quebec, Canada. The objective was to determine which bioassays...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808167/ https://www.ncbi.nlm.nih.gov/pubmed/35126097 http://dx.doi.org/10.3389/fphar.2021.511078 |
_version_ | 1784643826278727680 |
---|---|
author | Hall, Braydon Rapinski, Michel Spoor, Danielle Eid, Hoda Saleem, Ammar Arnason, John T. Foster, Brian Cuerrier, Alain Haddad, Pierre S. Harris, Cory S. |
author_facet | Hall, Braydon Rapinski, Michel Spoor, Danielle Eid, Hoda Saleem, Ammar Arnason, John T. Foster, Brian Cuerrier, Alain Haddad, Pierre S. Harris, Cory S. |
author_sort | Hall, Braydon |
collection | PubMed |
description | An ethnopharmacological metanalysis was conducted with a large database available on antidiabetic activities of plant foods and medicines from the northern boreal forest, which are traditionally used by the indigenous Cree of James Bay, Quebec, Canada. The objective was to determine which bioassays are closely associated with the traditional knowledge of the Cree and which pharmacological metrics and phytochemical signals best define these plants and their groups. Data from 17 plant species, ethnobotanically ranked by syndromic importance value for treatment of 15 diabetic symptoms, was used along with 49 bioassay endpoints reported across numerous pharmacological studies and a metabolomics dataset. Standardized activities were separated into primary, secondary and safety categories and summed to produce a Pharmacological Importance Value (PIV) in each of the three categories for each species. To address the question of which pharmacological metrics and phytochemical signals best define the CEI anti-diabetes plants, multivariate analyses were undertaken to determine groupings of plant families and plant parts. The analysis identified Larix larcina as the highest PIV species in primary assays, Salix planifolia in secondary assays, and Kalmia angustifolia in safety assays, as well as a ranking of other less active species by PIV. Multivariate analysis showed that activity in safety PIV monitored mainly with cytochrome P450 inhibition patterns best reflected patterns of traditional medicine importance in Cree traditional knowledge, whereas potent primary bioactivities were seen in individual plants determined to be most important to the Cree for anti-diabetes purposes. In the secondary anti-diabetes assays, pharmacological variability was better described by plant biology, mostly in terms of the plant part used. Key signal in the metabolomics loadings plots for activity were phenolics especially quercetin derivatives. Traditional Indigenous knowledge in this analysis was shown to be able to guide the identification of plant pharmacological qualities in scientific terms. |
format | Online Article Text |
id | pubmed-8808167 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88081672022-02-03 A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee Hall, Braydon Rapinski, Michel Spoor, Danielle Eid, Hoda Saleem, Ammar Arnason, John T. Foster, Brian Cuerrier, Alain Haddad, Pierre S. Harris, Cory S. Front Pharmacol Pharmacology An ethnopharmacological metanalysis was conducted with a large database available on antidiabetic activities of plant foods and medicines from the northern boreal forest, which are traditionally used by the indigenous Cree of James Bay, Quebec, Canada. The objective was to determine which bioassays are closely associated with the traditional knowledge of the Cree and which pharmacological metrics and phytochemical signals best define these plants and their groups. Data from 17 plant species, ethnobotanically ranked by syndromic importance value for treatment of 15 diabetic symptoms, was used along with 49 bioassay endpoints reported across numerous pharmacological studies and a metabolomics dataset. Standardized activities were separated into primary, secondary and safety categories and summed to produce a Pharmacological Importance Value (PIV) in each of the three categories for each species. To address the question of which pharmacological metrics and phytochemical signals best define the CEI anti-diabetes plants, multivariate analyses were undertaken to determine groupings of plant families and plant parts. The analysis identified Larix larcina as the highest PIV species in primary assays, Salix planifolia in secondary assays, and Kalmia angustifolia in safety assays, as well as a ranking of other less active species by PIV. Multivariate analysis showed that activity in safety PIV monitored mainly with cytochrome P450 inhibition patterns best reflected patterns of traditional medicine importance in Cree traditional knowledge, whereas potent primary bioactivities were seen in individual plants determined to be most important to the Cree for anti-diabetes purposes. In the secondary anti-diabetes assays, pharmacological variability was better described by plant biology, mostly in terms of the plant part used. Key signal in the metabolomics loadings plots for activity were phenolics especially quercetin derivatives. Traditional Indigenous knowledge in this analysis was shown to be able to guide the identification of plant pharmacological qualities in scientific terms. Frontiers Media S.A. 2022-01-18 /pmc/articles/PMC8808167/ /pubmed/35126097 http://dx.doi.org/10.3389/fphar.2021.511078 Text en Copyright © 2022 Hall, Rapinski, Spoor, Eid, Saleem, Arnason, Foster, Cuerrier, Haddad and Harris. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Hall, Braydon Rapinski, Michel Spoor, Danielle Eid, Hoda Saleem, Ammar Arnason, John T. Foster, Brian Cuerrier, Alain Haddad, Pierre S. Harris, Cory S. A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title | A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title_full | A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title_fullStr | A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title_full_unstemmed | A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title_short | A Multivariate Approach to Ethnopharmacology: Antidiabetic Plants of Eeyou Istchee |
title_sort | multivariate approach to ethnopharmacology: antidiabetic plants of eeyou istchee |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8808167/ https://www.ncbi.nlm.nih.gov/pubmed/35126097 http://dx.doi.org/10.3389/fphar.2021.511078 |
work_keys_str_mv | AT hallbraydon amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT rapinskimichel amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT spoordanielle amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT eidhoda amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT saleemammar amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT arnasonjohnt amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT fosterbrian amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT cuerrieralain amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT haddadpierres amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT harriscorys amultivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT hallbraydon multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT rapinskimichel multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT spoordanielle multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT eidhoda multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT saleemammar multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT arnasonjohnt multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT fosterbrian multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT cuerrieralain multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT haddadpierres multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee AT harriscorys multivariateapproachtoethnopharmacologyantidiabeticplantsofeeyouistchee |